You are here: All Products  > Chipscreen NewWay Starts China Trial of PD-1/CD40 Bispecific for Solid Tumor Cancers

Chipscreen NewWay Starts China Trial of PD-1/CD40 Bispecific for Solid Tumor Cancers

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products